Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 13
2019 19
2020 22
2021 28
2022 27
2023 27
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.
Ciscar M, Trinidad EM, Perez-Chacon G, Alsaleem M, Jimenez M, Jimenez-Santos MJ, Perez-Montoyo H, Sanz-Moreno A, Vethencourt A, Toss M, Petit A, Soler-Monso MT, Lopez V, Gomez-Miragaya J, Gomez-Aleza C, Dobrolecki LE, Lewis MT, Bruna A, Mouron S, Quintela-Fandino M, Al-Shahrour F, Martinez-Aranda A, Sierra A, Green AR, Rakha E, Gonzalez-Suarez E. Ciscar M, et al. Among authors: toss m. EMBO Mol Med. 2023 Apr 11;15(4):e16715. doi: 10.15252/emmm.202216715. Epub 2023 Mar 7. EMBO Mol Med. 2023. PMID: 36880458 Free PMC article.
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.
Makhlouf S, Wahab N, Toss M, Ibrahim A, Lashen AG, Atallah NM, Ghannam S, Jahanifar M, Lu W, Graham S, Mongan NP, Bilal M, Bhalerao A, Snead D, Minhas F, Raza SEA, Rajpoot N, Rakha E. Makhlouf S, et al. Among authors: toss m. Br J Cancer. 2023 Nov;129(11):1747-1758. doi: 10.1038/s41416-023-02451-3. Epub 2023 Sep 30. Br J Cancer. 2023. PMID: 37777578 Free PMC article.
Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade.
Alblihy A, Ali R, Algethami M, Ritchie AA, Shoqafi A, Alqahtani S, Mesquita KA, Toss MS, Ordóñez-Morán P, Jeyapalan JN, Dekker L, Salerno M, Hartsuiker E, Grabowska AM, Rakha EA, Mongan NP, Madhusudan S. Alblihy A, et al. Among authors: toss ms. Int J Mol Sci. 2023 Jun 30;24(13):10966. doi: 10.3390/ijms241310966. Int J Mol Sci. 2023. PMID: 37446144 Free PMC article.
Atypia in breast pathology: what pathologists need to know.
Katayama A, Toss MS, Parkin M, Ellis IO, Quinn C, Rakha EA. Katayama A, et al. Among authors: toss ms. Pathology. 2022 Feb;54(1):20-31. doi: 10.1016/j.pathol.2021.09.008. Epub 2021 Dec 3. Pathology. 2022. PMID: 34872753 Review.
Invasion in breast lesions: the role of the epithelial-stroma barrier.
Rakha EA, Miligy IM, Gorringe KL, Toss MS, Green AR, Fox SB, Schmitt FC, Tan PH, Tse GM, Badve S, Decker T, Vincent-Salomon A, Dabbs DJ, Foschini MP, Moreno F, Wentao Y, Geyer FC, Reis-Filho JS, Pinder SE, Lakhani SR, Ellis IO. Rakha EA, et al. Among authors: toss ms. Histopathology. 2018 Jun;72(7):1075-1083. doi: 10.1111/his.13446. Epub 2018 Feb 13. Histopathology. 2018. PMID: 29197112 Free article. Review.
Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer.
Lothion-Roy J, Haigh DB, Harris AE, Metzler VM, Alsaleem M, Toss MS, Kariri Y, Ntekim A, Robinson BD, Khani F, Gudas LJ, Allegrucci C, James VH, Madhusudan S, Mather M, Emes RD, Archer N, Fray RG, Rakha E, Jeyapalan JN, Rutland CS, Mongan NP, Woodcock CL. Lothion-Roy J, et al. Among authors: toss ms. Front Genet. 2023 Jan 12;13:1096071. doi: 10.3389/fgene.2022.1096071. eCollection 2022. Front Genet. 2023. PMID: 36733939 Free PMC article.
114 results